Lane Rosen, MD
Radiation Oncology · Shreveport, LANPI 1831119197
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (31.2%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Ion Beam Applications S.A. at 41.5% of the total. Reporting peaked in 2024 at $2,528 and has fallen 87.2% since, to $324 in 2025. Among radiation oncology clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 60 payments — averaging $164.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ion Beam Applications S.A.$4K
- Merck$2K
- IBA Proton Therapy, Inc.$2K
- Accuray Incorporated$489
- Elekta, Inc.$473
- Myriad Genetic Laboratories, Inc.$208
- plus $947 from 19 others
What the payments were for
- Consulting fees$3,08531%
- Speaking & faculty fees$2,33824%
- Travel & lodging$1,50015%
- Food & beverage$2,95630%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ion Beam Applications S.A. | 5 | $4,097 |
| Merck | 1 | $2,135 |
| IBA Proton Therapy, Inc. | 4 | $1,531 |
| Accuray Incorporated | 6 | $489 |
| Elekta, Inc. | 7 | $473 |
| Myriad Genetic Laboratories, Inc. | 2 | $208 |
| Novartis | 8 | $169 |
| Philips North America LLC | 1 | $122 |
| GE HealthCare | 3 | $96 |
| Siemens Medical Solutions USA, Inc. | 4 | $90 |
| Teleflex LLC | 1 | $56 |
| Profound Medical Corp. | 2 | $55 |
| Stryker | 1 | $51 |
| Boston Scientific | 2 | $44 |
| Reflexion Medical, Inc. | 1 | $37 |
| Bayer | 2 | $37 |
| Brainlab, Inc. | 2 | $34 |
| Progenics Pharmaceuticals, Inc. | 1 | $28 |
| Myocardial Solutions, Inc. | 1 | $23 |
| Bioprotect Medical, Inc. | 1 | $21 |
| Palette Life Sciences, Inc. | 1 | $19 |
| Tempus AI, Inc | 1 | $19 |
| Tactile Systems Technology Inc | 1 | $17 |
| Fortovia Therapeutics, Inc. | 1 | $15 |
| Advanced Accelerator Applications | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TomoTherapy System$385
- Prolaris$125
- CyberKnife System$123
- Trilogy 100$122
- Unity$113
How this compares
$9,879 in reported general payments places this provider in the 95th percentile of 58 radiation oncology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 11 | $119 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Shreveport
- Chiachien WangShreveport$31K
- Troy RichardsShreveport$3K
- Daniella DangShreveport$2K
- Sanford KatzShreveport$1K
- Michael DurciShreveport$1K
- Russell AndersonShreveport$878
- Federico AmpilShreveport$291
- James RussoLafayette$20K
- Konstantin KovtunBaton Rouge$3K
- James MazeLake Charles$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.